Zoledronate Early to Hip Fracture Patients - Safe and Effective?

PHASE4RecruitingINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Hip FracturesOsteoporosis

Interventions

DRUG

Zoledronic Acid 5Mg/Bag 100Ml Inj

100ml Zoledronic acid (5mg/100ml) administered intravenously

DRUG

sodium chloride

100ml NaCl 9mg/ml administered intravenously

Trial Locations (1)

RECRUITING

Oslo University Hospital, Oslo

All Listed Sponsors

collaborator

Vestre Viken Hospital Trust

OTHER

collaborator

Roche Diagnostics GmbH

INDUSTRY

collaborator

Diakonhjemmet Hospital

OTHER

lead

Lene Bergendal Solberg

OTHER

NCT05025293 - Zoledronate Early to Hip Fracture Patients - Safe and Effective? | Biotech Hunter | Biotech Hunter